Bactiguard launches Hydrocyn aqua in Greece
Comunicato Precedente
Comunicato Successivo
Hydrocyn® aqua was included in Bactiguard's portfolio of products for infection prevention following the acquisition of Vigilenz in early 2020. Hydrocyn was launched in Sweden in March 2020 and the market expansion now continues in Europe, the Middle East, India and Southeast Asia.
Hydrocyn is a non-alcoholic and pH-neutral product line that contains hypochlorous acid, the same substance as the body's immune cells use in their defense against infectious microbes. Hydrocyn effectively kills most viruses, bacteria and fungi that cause infections and, at the same time, does not cause any irritation to the skin or body.
Lifecyn is a privately owned enterprise, geared by the aspiration to provide people with innovative, science-based antiseptic and wound care solutions. The company has a long extensive experience in the Greek and other European markets with a distribution capacity covering the whole country. Lifecyn focuses on highly sophisticated, quality consumer healthcare lines that promote people's safety, healing and personal wellbeing.
For further information, please contact:
Gabriella Caracciolo, CFO and deputy CEO, mobile +46 72 141 62 49
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/bactiguard-holding-ab--publ-/r/bactiguard-launches-hydrocyn-aqua-in-greece,c3265842
The following files are available for download:
|
https://mb.cision.com/Main/9686/3265842/1358071.pdf |
210112 Bactiguard launches Hydrocyn aqua in Greece |
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/bactiguard-holding-ab--publ-/r/bactiguard-launches-hydrocyn-aqua-in-greece,c3265842
The following files are available for download:
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




